Cargando…
Anti-fibrosis activity of combination therapy with epigallocatechin gallate, taurine and genistein by regulating glycolysis, gluconeogenesis, and ribosomal and lysosomal signaling pathways in HSC-T6 cells
A previous study by our group indicated that combined treatment with taurine, epigallocatechin gallate (EGCG) and genistein protects against liver fibrosis. The aim of the present study was to elucidate the antifibrotic mechanism of this combination treatment using isobaric tag for relative and abso...
Autores principales: | Li, Yan, Zhu, Min, Huo, Yani, Zhang, Xuerong, Liao, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257822/ https://www.ncbi.nlm.nih.gov/pubmed/30542382 http://dx.doi.org/10.3892/etm.2018.6743 |
Ejemplares similares
-
Combined Taurine, Epigallocatechin Gallate and Genistein Therapy Reduces HSC-T6 Cell Proliferation and Modulates the Expression of Fibrogenic Factors
por: Li, Yan, et al.
Publicado: (2013) -
Correction: Yan, L., et al. Combined Taurine, Epigallocatechin Gallate and Genistein Therapy Reduces HSC-T6 Cell Proliferation and Modulates the Expression of Fibrogenic Factors. Int. J. Mol. Sci. 2013, 14, 20543–20554
por: Li, Yan, et al.
Publicado: (2021) -
Targeting Glycolysis with Epigallocatechin-3-Gallate Enhances the Efficacy of Chemotherapeutics in Pancreatic Cancer Cells and Xenografts
por: Wei, Ran, et al.
Publicado: (2019) -
Inhibition Mechanisms of (−)-Epigallocatechin-3-gallate
and Genistein on Amyloid-beta 42 Peptide of Alzheimer’s Disease
via Molecular Simulations
por: Fang, Mei, et al.
Publicado: (2022) -
Glycolysis and gluconeogenesis: A teaching view
por: Hernández, Félix
Publicado: (2020)